Swiss fine chemical and contract manufacturing company Lonza has agreed to buy Arch Chemicals of the USA for $1.2 billion …
Indian drugmaker Cadila Healthcare has been taken to task by the US FDA for quality violations at a new sterile …

Merck & Co continues to shake up its network of facilities, deciding to close a recently-acquired site in the USA …
Pfizer has decided to buy back a manufacturing facility in Rouses Point, New York, from current owner Akrimax Pharmaceuticals, and …
A team of researchers in the USA have successfully synthesised human collagen in transgenic maize seeds, offering a potential alternative …
Latvian pharmaceutical company Grindeks has opened a new active pharmaceutical ingredient (API) manufacturing plant that it predicts will add around …
The European Medicines Agency has approved a second manufacturing facility in the USA for Shire’s Fabry disease treatment Replagal. Shire’s …
GlaxoSmithKline has agreed to pay almost $41 million to dozens of US states in a lawsuit focusing on alleged substandard …
Abbott delays closure of Canadian facility, West Pharma starts a new build in China, plus updates from Vetter, Pharmadule and …
Pfizer is selling its Irish manufacturing facility in Shanbally, Cork, to US biopharmaceutical company BioMarin for $48.5 million, creating up …

Novo Nordisk plans to invest almost 1 billion Danish kroner (134 million euros) in a new biologics manufacturing facility at …

A pilot project set up earlier this year to encourage the adoption of quality-by-design in pharmaceutical manufacturing has passed its …
Novartis has started construction of its new pharmaceutical manufacturing plant in St. Petersburg, Russia.The company has broken ground on the …
Indian drugmaker Dr Reddy’s Laboratories has been sent a warning letter by the US FDA after a manufacturing facility in …
Johnson & Johnson continues to be plagued by product recalls, with the latest involving two lots of its schizophrenia drug …